Immunological studies of SK2 hybridoma cells microencapsulated with alginate-poly(L)lysine-alginate (APA) membrane following allogeneic transplantation

被引:33
作者
Okada, N
Miyamoto, H
Yoshioka, T
Sakamoto, K
Katsume, A
Saito, H
Nakagawa, S
Ohsugi, Y
Mayumi, T
机构
[1] OSAKA UNIV,FAC PHARMACEUT SCI,SUITA,OSAKA 565,JAPAN
[2] OSAKA UNIV,GRAD SCH PHARMACEUT SCI,SUITA,OSAKA 565,JAPAN
[3] CHUGAI PHARMACEUT CO LTD,FUJI GOTEMBA RES LABS,GOTEMBA,SHIZUOKA 412,JAPAN
关键词
D O I
10.1006/bbrc.1996.5996
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Microencapsulation of living cells or tissues has been proposed to prevent their immune destruction following transplantation. In this study, we examined whether SK2 hybridoma cells microencapsulated in an alginate-poly(L)lysine-alginate (APA) membrane (APA-SK2 cells) were immunoisolated from the allogeneic host's immune system using a cytotoxicity test. The APA membrane inhibited the activation of the host's cellular immune response, but did not prevent the production of cytotoxic antibodies against entrapped SK2 cells following allogeneic transplantation. However, the APA-SK2 cells remained vital in SK2 cell-immunized mice as well as in intact mice. We considered that complement regulatory factors which were present on cell membrane and had species-specific restriction blocked the complement-mediated cell lysis on allogeneic transplantation, since APA-SK2 cells were destroyed by rabbit anti-SK2 cell antiserum. Our results demonstrated that APA membrane could inhibit cell-cell contact between entrapped cells and the host's lymphocytes, but could not completely protect the entrapped cells from xenogeneic humoral immunity. (C) 1997 Academic Press.
引用
收藏
页码:524 / 527
页数:4
相关论文
共 18 条
  • [1] Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients
    Aebischer, P
    Schluep, M
    Deglon, N
    Joseph, JM
    Hirt, L
    Heyd, B
    Goddard, M
    Hammang, JP
    Zurn, AD
    Kato, AC
    Regli, F
    Baetge, EE
    [J]. NATURE MEDICINE, 1996, 2 (06) : 696 - 699
  • [2] Fryer J P, 1995, Transpl Immunol, V3, P21, DOI 10.1016/0966-3274(95)80002-6
  • [3] HAMMER C, 1992, TRANSPLANT P, V24, P2397
  • [4] DELIVERY OF A SECRETABLE ADENOSINE-DEAMINASE THROUGH MICROCAPSULES - A NOVEL-APPROACH TO SOMATIC GENE-THERAPY
    HUGHES, M
    VASSILAKOS, A
    ANDREWS, DW
    HORTELANO, G
    BELMONT, JW
    CHANG, PL
    [J]. HUMAN GENE THERAPY, 1994, 5 (12) : 1445 - 1455
  • [5] STRATEGY FOR DEVELOPING MICROBEADS APPLICABLE TO ISLET XENOTRANSPLANTATION INTO A SPONTANEOUS DIABETIC NOD MOUSE
    IWATA, H
    TAKAGI, T
    KOBAYASHI, K
    OKA, T
    TSUJI, T
    ITO, F
    [J]. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1994, 28 (10): : 1201 - 1207
  • [6] IMPLANTATION OF ENCAPSULATED CATECHOLAMINE AND GDNF-PRODUCING CELLS IN RATS WITH UNILATERAL DOPAMINE DEPLETIONS AND PARKINSONIAN SYMPTOMS
    LINDNER, MD
    WINN, SR
    BAETGE, EE
    HAMMANG, JP
    GENTILE, FT
    DOHERTY, E
    MCDERMOTT, PE
    FRYDEL, B
    ULLMAN, MD
    SCHALLERT, T
    EMERICH, DF
    [J]. EXPERIMENTAL NEUROLOGY, 1995, 132 (01) : 62 - 76
  • [7] MICROENCAPSULATION OF GENETICALLY-ENGINEERED FIBROBLASTS SECRETING NERVE GROWTH-FACTOR
    MAYSINGER, D
    PICCARDO, P
    FILIPOVICGRCIC, J
    CUELLO, AC
    [J]. NEUROCHEMISTRY INTERNATIONAL, 1993, 23 (02) : 123 - 129
  • [8] HUMAN-COMPLEMENT REGULATORY PROTEINS PROTECT SWINE-TO-PRIMATE CARDIAC XENOGRAFTS FROM HUMORAL INJURY
    MCCURRY, KR
    KOOYMAN, DL
    ALVARADO, CG
    COTTERELL, AH
    MARTIN, MJ
    LOGAN, JS
    PLATT, JL
    [J]. NATURE MEDICINE, 1995, 1 (05) : 423 - 427
  • [9] ODAKA N, IN PRESS BIOCH BIOPH
  • [10] INTERLEUKIN-6 CDNA TRANSFECTED LEWIS LUNG-CARCINOMA CELLS SHOW UNALTERED NET TUMOR-GROWTH RATE BUT CAUSE WEIGHT-LOSS AND SHORTEN SURVIVAL IN SYNGENIC MICE
    OHE, Y
    PODACK, ER
    OLSEN, KJ
    MIYAHARA, Y
    MIURA, K
    SAITO, H
    KOISHIHARA, Y
    OHSUGI, Y
    OHIRA, T
    NISHIO, K
    SAIJO, N
    [J]. BRITISH JOURNAL OF CANCER, 1993, 67 (05) : 939 - 944